1. Home
  2. ALT vs OLP Comparison

ALT vs OLP Comparison

Compare ALT & OLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • OLP
  • Stock Information
  • Founded
  • ALT 1997
  • OLP 1982
  • Country
  • ALT United States
  • OLP United States
  • Employees
  • ALT 59
  • OLP N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • OLP Real Estate Investment Trusts
  • Sector
  • ALT Health Care
  • OLP Real Estate
  • Exchange
  • ALT Nasdaq
  • OLP Nasdaq
  • Market Cap
  • ALT 501.9M
  • OLP 478.2M
  • IPO Year
  • ALT N/A
  • OLP N/A
  • Fundamental
  • Price
  • ALT $4.86
  • OLP $20.59
  • Analyst Decision
  • ALT Strong Buy
  • OLP
  • Analyst Count
  • ALT 7
  • OLP 0
  • Target Price
  • ALT $16.33
  • OLP N/A
  • AVG Volume (30 Days)
  • ALT 3.2M
  • OLP 80.0K
  • Earning Date
  • ALT 11-06-2025
  • OLP 11-06-2025
  • Dividend Yield
  • ALT N/A
  • OLP 8.90%
  • EPS Growth
  • ALT N/A
  • OLP N/A
  • EPS
  • ALT N/A
  • OLP 1.54
  • Revenue
  • ALT $20,000.00
  • OLP $97,423,000.00
  • Revenue This Year
  • ALT N/A
  • OLP $8.44
  • Revenue Next Year
  • ALT N/A
  • OLP $3.05
  • P/E Ratio
  • ALT N/A
  • OLP $13.14
  • Revenue Growth
  • ALT N/A
  • OLP 9.29
  • 52 Week Low
  • ALT $2.90
  • OLP $19.62
  • 52 Week High
  • ALT $10.88
  • OLP $30.46
  • Technical
  • Relative Strength Index (RSI)
  • ALT 68.61
  • OLP 48.99
  • Support Level
  • ALT $4.40
  • OLP $20.13
  • Resistance Level
  • ALT $4.75
  • OLP $20.76
  • Average True Range (ATR)
  • ALT 0.29
  • OLP 0.41
  • MACD
  • ALT 0.07
  • OLP 0.06
  • Stochastic Oscillator
  • ALT 95.22
  • OLP 76.88

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About OLP One Liberty Properties Inc.

One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.

Share on Social Networks: